In addition, ALKBH5 suppressed the immune function of antitumour T cells in intrahepatic cholangiocarcinoma (ICC) by upregulating PD‐L1 expression.125. This evidence concerns the gene ALKBH5 and intrahepatic cholangiocarcinoma.